Sort by
Refine Your Search
-
Listed
-
Country
-
Program
-
Field
-
St. Jude is seeking outstanding candidates for postdoctoral fellowship positions in the Childhood Hematological Malignancies Training Program. This prestigious, NIH-sponsored T32 training program
-
A postdoctoral position is available for highly motivated individuals with a background in Computational Neuroscience to analyze complex time-series data from ongoing 2-photon microscopy experiments
-
The newly established Program for Memory Longevity (PML), led by Attila Losonczy, MD, PhD, in the O’Donnell Brain Institute (OBI) and the Department of Neuroscience at the University of Texas
-
diverse academic backgrounds to contribute to our projects in areas such as: Network Security, Information Assurance, Model-driven Security, Cloud Computing, Cryptography, Satellite Systems, Vehicular
-
algorithms, clinical decision support systems, and population health management platforms. Evaluate emerging technologies in clinical informatics and provide strategic recommendations for their adoption within
-
NORPOD is a collaborative postdoctoral program of the Nordic EMBL Partnership for Molecular Medicine . The partnership is a network of four national research centers across the Nordics and the
-
We are seeking a highly motivated and creative candidate for a fully supported postdoctoral fellowship to develop immune-based therapies. Specifically, the research is aimed to develop cell-based immunotherapies for pediatric tumors. Studies are focused on using genetic engineering approaches to...
-
The Department of Computational Biology is seeking a motivated and innovative Lead Researcher in Flow Cytometry. This researcher will work closely with the Computational Biology Genomics Laboratory
-
cell fate and circuit formation in developing Drosophila brains. The lab combines a variety of cutting-edge experimental and computational techniques including single-cell RNA and ATAC sequencing
-
mechanisms linking cardiovascular diseases with cancer and cancer therapies. She uses human-induced pluripotent stem cells (iPSCs), patient-derived samples, genomics, and computational biology to identify